TherapeuticsMD (TXMD) EBITDA Margin Growth (5y) (2016 - 2026)
TherapeuticsMD (TXMD) EBITDA Margin Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | TherapeuticsMD | 23.67 Mn | 14.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,904.00 |
| Mar 31, 2026 | 4,752.00 |
| Dec 31, 2025 | -2,052.00 |
| Sep 30, 2025 | 1,917.00 |
| Jun 30, 2025 | 34,787.00 |
| Mar 31, 2025 | 8,970.00 |
| Dec 31, 2024 | 18,141.00 |
| Sep 30, 2024 | -9,318.00 |
| Jun 30, 2024 | -50,695.00 |
| Mar 31, 2024 | 60,056.00 |
| Dec 31, 2023 | 40,558.00 |
| Sep 30, 2023 | -211,090.00 |
| Jun 30, 2023 | 34,116.00 |
| Mar 31, 2023 | 2,047.00 |
| Dec 31, 2022 | 59,624.00 |
| Sep 30, 2022 | -368,858.00 |
| Jun 30, 2022 | -372,163.00 |
| Mar 31, 2022 | -199,044.00 |
| Dec 31, 2021 | 32,179.00 |
| Sep 30, 2021 | 29,677.00 |